NO20015600L - Anvendelse av 1,4-benzotiazepin-derivater som legemidler for å overvinne resistens mot anticancer legemidler - Google Patents
Anvendelse av 1,4-benzotiazepin-derivater som legemidler for å overvinne resistens mot anticancer legemidlerInfo
- Publication number
- NO20015600L NO20015600L NO20015600A NO20015600A NO20015600L NO 20015600 L NO20015600 L NO 20015600L NO 20015600 A NO20015600 A NO 20015600A NO 20015600 A NO20015600 A NO 20015600A NO 20015600 L NO20015600 L NO 20015600L
- Authority
- NO
- Norway
- Prior art keywords
- drugs
- anticancer
- anticancer drugs
- resistance
- overcoming
- Prior art date
Links
- 239000002246 antineoplastic agent Substances 0.000 title abstract 7
- 229940041181 antineoplastic drug Drugs 0.000 title abstract 7
- 229940079593 drug Drugs 0.000 title abstract 3
- 239000003814 drug Substances 0.000 title abstract 3
- KYVHGCKMVJDCNV-UHFFFAOYSA-N 1,4-benzothiazepine Chemical class S1C=CN=CC2=CC=CC=C12 KYVHGCKMVJDCNV-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 230000000694 effects Effects 0.000 abstract 3
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 230000002708 enhancing effect Effects 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP13919699 | 1999-05-19 | ||
| PCT/JP2000/003216 WO2000071132A1 (fr) | 1999-05-19 | 2000-05-19 | Utilisation de derives 1,4-benzothiazepine en tant que medicaments contre la tolerance cancerostatique |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20015600D0 NO20015600D0 (no) | 2001-11-16 |
| NO20015600L true NO20015600L (no) | 2001-12-20 |
Family
ID=15239803
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20015600A NO20015600L (no) | 1999-05-19 | 2001-11-16 | Anvendelse av 1,4-benzotiazepin-derivater som legemidler for å overvinne resistens mot anticancer legemidler |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6977252B1 (fr) |
| EP (1) | EP1184037B1 (fr) |
| KR (1) | KR100686617B1 (fr) |
| CN (1) | CN1178663C (fr) |
| AT (1) | ATE298575T1 (fr) |
| AU (1) | AU774656B2 (fr) |
| CA (1) | CA2373484C (fr) |
| DE (1) | DE60021075T2 (fr) |
| NO (1) | NO20015600L (fr) |
| TW (1) | TWI221093B (fr) |
| WO (1) | WO2000071132A1 (fr) |
| ZA (1) | ZA200109334B (fr) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7393652B2 (en) | 2000-05-10 | 2008-07-01 | The Trustees Of Columbia University In The City Of New York | Methods for identifying a chemical compound that directly enhances binding of FKBP12.6 to PKA-phosphorylated type 2 ryanodine receptor (RyR2) |
| US7879840B2 (en) | 2005-08-25 | 2011-02-01 | The Trustees Of Columbia University In The City Of New York | Agents for preventing and treating disorders involving modulation of the RyR receptors |
| US7718644B2 (en) | 2004-01-22 | 2010-05-18 | The Trustees Of Columbia University In The City Of New York | Anti-arrhythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2) and uses thereof |
| US8022058B2 (en) | 2000-05-10 | 2011-09-20 | The Trustees Of Columbia University In The City Of New York | Agents for preventing and treating disorders involving modulation of the RyR receptors |
| US7544678B2 (en) | 2002-11-05 | 2009-06-09 | The Trustees Of Columbia University In The City Of New York | Anti-arrythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2) |
| JP2007525165A (ja) | 2003-03-07 | 2007-09-06 | トラスティーズ・オブ・コロンビア・ユニバーシティ・イン・ザ・シティ・オブ・ニューヨーク | タイプ１ライアノジン受容体に基づく方法 |
| US8710045B2 (en) | 2004-01-22 | 2014-04-29 | The Trustees Of Columbia University In The City Of New York | Agents for preventing and treating disorders involving modulation of the ryanodine receptors |
| CN1311818C (zh) * | 2004-11-22 | 2007-04-25 | 山东蓝金生物工程有限公司 | 一种抗实体肿瘤的药物组合物 |
| US7704990B2 (en) | 2005-08-25 | 2010-04-27 | The Trustees Of Columbia University In The City Of New York | Agents for preventing and treating disorders involving modulation of the RyR receptors |
| US8835506B2 (en) | 2008-06-05 | 2014-09-16 | Stc.Unm | Methods and related compositions for the treatment of cancer |
| DK3176164T3 (da) | 2014-07-30 | 2019-10-28 | Aetas Pharma Co Ltd | Optisk isomer af 1,4-benzothiazepin-1-oxidderivat og farmaceutisk sammensætning fremstillet ved anvendelse deraf |
| KR102440098B1 (ko) * | 2020-07-31 | 2022-09-05 | 부산대학교 산학협력단 | Agr2의 동종이량체를 표적으로 하는 저분자 화합물을 유효성분으로 함유하는 암 예방 또는 치료용 조성물 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS579712A (en) * | 1980-06-20 | 1982-01-19 | Fukumi Morishige | Instilling (dripping) liquid for intravenous injection |
| JP2703408B2 (ja) | 1990-12-28 | 1998-01-26 | 麒麟麦酒株式会社 | １，４‐ベンゾチアゼピン誘導体 |
| JP3093419B2 (ja) | 1992-03-30 | 2000-10-03 | 麒麟麦酒株式会社 | １，４‐ベンゾチアゼピン誘導体 |
| US5643909A (en) | 1993-04-19 | 1997-07-01 | Syntex (U.S.A.) Inc. | 10,11-Methanodibenzosuberane derivatives |
| US5700826A (en) | 1995-06-07 | 1997-12-23 | Ontogen Corporation | 1,2,4,5-tetra substituted imidazoles as modulators of multi-drug resistance |
| JP4063964B2 (ja) | 1998-08-12 | 2008-03-19 | 金子 昇 | 神経細胞保護薬 |
-
2000
- 2000-05-19 WO PCT/JP2000/003216 patent/WO2000071132A1/fr not_active Ceased
- 2000-05-19 AT AT00929801T patent/ATE298575T1/de not_active IP Right Cessation
- 2000-05-19 CA CA002373484A patent/CA2373484C/fr not_active Expired - Fee Related
- 2000-05-19 DE DE60021075T patent/DE60021075T2/de not_active Expired - Lifetime
- 2000-05-19 EP EP00929801A patent/EP1184037B1/fr not_active Expired - Lifetime
- 2000-05-19 KR KR1020017014755A patent/KR100686617B1/ko not_active Expired - Fee Related
- 2000-05-19 CN CNB008103631A patent/CN1178663C/zh not_active Expired - Fee Related
- 2000-05-19 AU AU47783/00A patent/AU774656B2/en not_active Ceased
- 2000-05-19 US US09/979,231 patent/US6977252B1/en not_active Expired - Fee Related
- 2000-07-17 TW TW089114236A patent/TWI221093B/zh not_active IP Right Cessation
-
2001
- 2001-11-13 ZA ZA200109334A patent/ZA200109334B/xx unknown
- 2001-11-16 NO NO20015600A patent/NO20015600L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200109334B (en) | 2003-01-29 |
| DE60021075T2 (de) | 2006-05-24 |
| EP1184037A4 (fr) | 2003-12-03 |
| KR20020008407A (ko) | 2002-01-30 |
| DE60021075D1 (de) | 2005-08-04 |
| EP1184037A1 (fr) | 2002-03-06 |
| AU774656B2 (en) | 2004-07-01 |
| US6977252B1 (en) | 2005-12-20 |
| CN1361693A (zh) | 2002-07-31 |
| NO20015600D0 (no) | 2001-11-16 |
| TWI221093B (en) | 2004-09-21 |
| ATE298575T1 (de) | 2005-07-15 |
| WO2000071132A1 (fr) | 2000-11-30 |
| CA2373484C (fr) | 2009-01-20 |
| CN1178663C (zh) | 2004-12-08 |
| KR100686617B1 (ko) | 2007-02-23 |
| CA2373484A1 (fr) | 2000-11-30 |
| AU4778300A (en) | 2000-12-12 |
| EP1184037B1 (fr) | 2005-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60119894D1 (de) | Piperidinverbindungen und diese enthaltenden medikamente | |
| NO324249B1 (no) | Glykopyranosyloksybenzylbenzenderivater, medisinske sammensetninger inneholdende slike, samt intermediater til fremstilling av derivatene | |
| NO20015600L (no) | Anvendelse av 1,4-benzotiazepin-derivater som legemidler for å overvinne resistens mot anticancer legemidler | |
| DK1213296T3 (da) | Glucopyranosyloxpyrazolderivater, lægemidler indeholdende samme samt mellemprodukter til fremstilling heraf | |
| ATE271045T1 (de) | Sauerstoffhaltige heterocyclische verbindungen | |
| NO20014925D0 (no) | Farmasöytiske forbindelser | |
| PT976748E (pt) | Derivados de pirrolidina com actividade inibidora de fosfolipase a2 | |
| CY1111816T1 (el) | Παραγωγο θειαδιαζολινης για την θεραπεια του καρκινου | |
| EP1092435A4 (fr) | Medicaments antidiabetiques | |
| DK0514277T3 (da) | 3-aminopyradazinderivater med virkning på centralnervesystemet | |
| DE602005027213D1 (de) | Neue imidazolidinderivate | |
| NO20025035D0 (no) | Oksadiazolderivater som har anticancer-effekter | |
| DE69931051D1 (de) | Neue vinylbenzolderivate | |
| DE69623497D1 (de) | 1-methylcarbapenem-derivate | |
| DK0806413T3 (da) | 2-substituerede viatmin D3-derivater | |
| ATE134376T1 (de) | Mono- und bis-alkylaminoanthracycline | |
| WO2000010543A3 (fr) | Medicaments contenant des composes complexes de platine, et leur utilisation | |
| DE60238847D1 (de) | Pyrimidinderivate enthaltendes medikament | |
| NO20010244L (no) | Medikamenter inneholdende polyhydroksyalkylpyrazinderivater, deres fremstilling samt medikamenter inneholdende derivatene | |
| TH35543A (th) | สารประกอบเบนซอกซาซิพีน การผลิต และการใช้สารเหล่านี้ |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |